WHO ICTRP trial
Efficacy of prostaglandin E1 (alprostadil alfadex) in hemodialysis patients with…
JPRN-UMIN000005169 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000005169 |
|---|---|
| Public title | Efficacy of prostaglandin E1 (alprostadil alfadex) in hemodialysis patients with peripheral arterial disease (PAD): Examination of the therapeutic effect based on measurement of skin perfusion pressure (SPP) |
| Scientific title | Efficacy of prostaglandin E1 (alprostadil alfadex) in hemodialysis patients with peripheral arterial disease (PAD): Examination of the therapeutic effect based on measurement of skin perfusion pressure (SPP) - Efficacy of prostaglandin E1 (alprostadil alfadex) in hemodialysis patients with PAD |
| Primary sponsor | Ikegami General hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Peripheral Arterial Disease |
| Interventions | Prostaglandin E1 (PGE1) injection (brand name: prostaglandin for injection, generic name: alprostadil alfadex for injection) |
| Registration date | Mar 3, 2011 |
| Target size | 40 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: